BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27436330)

  • 1. Update on Mineral and Bone Disorders in Chronic Kidney Disease.
    Foster JD
    Vet Clin North Am Small Anim Pract; 2016 Nov; 46(6):1131-49. PubMed ID: 27436330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Secondary Renal Osteopathy Exist in Companion Animals?
    Segev G; Meltzer H; Shipov A
    Vet Clin North Am Small Anim Pract; 2016 Nov; 46(6):1151-62. PubMed ID: 27436331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Manifestations of Chronic Kidney Disease and Renal Secondary Hyperparathyroidism: A Comparative Review.
    Davis EM
    J Vet Dent; 2015; 32(2):87-98. PubMed ID: 26415385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease.
    Harjes LM; Parker VJ; Dembek K; Young GS; Giovaninni LH; Kogika MM; Chew DJ; Toribio RE
    J Vet Intern Med; 2017 May; 31(3):784-790. PubMed ID: 28419560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
    Molony DA; Stephens BW
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observation about phosphorus and protein supply in cats and dogs prior to the diagnosis of chronic kidney disease.
    Böswald LF; Kienzle E; Dobenecker B
    J Anim Physiol Anim Nutr (Berl); 2018 Apr; 102 Suppl 1():31-36. PubMed ID: 29623690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor-23 as an early marker of CKD-mineral bone disorder in dogs: preliminary investigation.
    Miyakawa H; Nagatani Y; Ogawa M; Nagakawa M; Sakatani A; Akabane R; Miyagawa Y; Takemura N
    J Small Anim Pract; 2020 Dec; 61(12):744-751. PubMed ID: 33037651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal model of human disease. Renal osteodystrophy in dogs with radiation nephropathy.
    Norrdin RW
    Am J Pathol; 1981 Jun; 103(3):466-9. PubMed ID: 7234972
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium metabolism and disorders of parathyroid glands.
    Capen CC; Martin SL
    Vet Clin North Am; 1977 Aug; 7(3):513-48. PubMed ID: 198934
    [No Abstract]   [Full Text] [Related]  

  • 12. Understanding and managing hyperphosphatemia in patients with chronic renal disease.
    Malluche HH; Monier-Faugere MC
    Clin Nephrol; 1999 Nov; 52(5):267-77. PubMed ID: 10584989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal secondary hyperparathyroidism in dogs.
    Stillion JR; Ritt MG
    Compend Contin Educ Vet; 2009 Jun; 31(6):E8. PubMed ID: 19746344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EOS789, a novel pan-phosphate transporter inhibitor, is effective for the treatment of chronic kidney disease-mineral bone disorder.
    Tsuboi Y; Ohtomo S; Ichida Y; Hagita H; Ozawa K; Iida M; Nagao S; Ikegami H; Takahashi T; Horiba N
    Kidney Int; 2020 Aug; 98(2):343-354. PubMed ID: 32624180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of phosphorus in the pathophysiology of chronic kidney disease.
    Geddes RF; Finch NC; Syme HM; Elliott J
    J Vet Emerg Crit Care (San Antonio); 2013; 23(2):122-33. PubMed ID: 23464730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
    Morio K; Koide K
    Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrous osteodystrophy with facial hyperostosis in a dog with renal cortical hypoplasia.
    Norrdin RW
    Cornell Vet; 1975 Apr; 65(2):173-86. PubMed ID: 1126166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Understanding of the Pathogenesis of Progressive Chronic Kidney Disease in Cats.
    Jepson RE
    Vet Clin North Am Small Anim Pract; 2016 Nov; 46(6):1015-48. PubMed ID: 27461408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A feline-focused review of chronic kidney disease-mineral and bone disorders - Part 1: Physiology of calcium handling.
    Tang PK; Geddes RF; Jepson RE; Elliott J
    Vet J; 2021 Sep; 275():105719. PubMed ID: 34311095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of feeding a renal diet on plasma fibroblast growth factor 23 concentrations in cats with stable azotemic chronic kidney disease.
    Geddes RF; Elliott J; Syme HM
    J Vet Intern Med; 2013; 27(6):1354-61. PubMed ID: 24010686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.